Histological Variants in Bladder Cancer—Adenocarcinoma

  • Sanchia S. GoonewardeneEmail author
  • Raj Persad
  • Hanif Motiwala
  • David Albala


Primary adenocarcinomas of the bladder and urachus are extremely rare, accounting for 0.5–2.0% of all bladder malignancies (Williams and Chavda in Rev Urol 17(1):46–49, 2015). This chapter covers clinical presentation and management of bladder adenocarcinoma including survival outcomes, urachal adenocarcinoma and chemotherapy in metastatic disease.


  1. Aoun F, Peltier A, van Velthoven R. Bladder sparing robot-assisted laparoscopic en bloc resection of urachus and umbilicus for urachal adenocarcinoma. J Robot Surg. 2015;9(2):167–70.CrossRefGoogle Scholar
  2. Burnett AL, Epstein JI, Marshall FF. Adenocarcinoma of urinary bladder: classification and management. Urology. 1991;37(4):315–21.CrossRefGoogle Scholar
  3. Busto Martín LA, Janeiro Pais M, González Dacal J, Chantada Abal V, Busto Castañón L. Signet-ring cell adenocarcinoma of the bladder: case series between 1990–2009. Arch Esp Urol. 2010;63(2):150–3.CrossRefGoogle Scholar
  4. Correa JJ, Hakky TS, Spiess PE, Chuang T, Sexton WJ. Robotic-assisted partial cystectomy with en bloc excision of the urachus and the umbilicus for urachal adenocarcinoma. J Robot Surg. 2010;3(4):235–8.CrossRefGoogle Scholar
  5. DeFillipo N, Blute R, Klein LA. Signet-ring cell carcinoma of bladder. Evaluation of three cases with review of literature. Urology. 1987;29(5):479–83.CrossRefGoogle Scholar
  6. Dutta R, Abdelhalim A, Martin JW, Vernez SL, Faltas B, Lotan Y, Youssef RF. Effect of tumor location on survival in urinary bladder adenocarcinoma: a population-based analysis. Urol Oncol. 2016;34(12):531.e1–6.CrossRefGoogle Scholar
  7. Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol. 2016;5(5):692–701.CrossRefGoogle Scholar
  8. Milhoua PM, Knoll A, Bleustein CB, Ghavamian R. Laparoscopic partial cystectomy for treatment of adenocarcinoma of the urachus. Urology. 2006;67(2):423.e15–7.CrossRefGoogle Scholar
  9. Pokuri VK, Sule N, Perfetto C, Duff M, Kopp C, Guru K, Shah D, George S. A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinoma. J Community Support Oncol. 2016;14(2):72–5.CrossRefGoogle Scholar
  10. Schultz RE, Bloch MJ, Tomaszewski JE, Brooks JS, Hanno PM. Mesonephric adenocarcinoma of the bladder. J Urol. 1984;132(2):263–5.CrossRefGoogle Scholar
  11. Teo M, Swan NC, McDermott RS. Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab. Nat Rev Urol. 2011;8(5):282–5.CrossRefGoogle Scholar
  12. Williams CR, Chavda K. En bloc robot-assisted laparoscopic partial cystectomy, urachal resection, and pelvic lymphadenectomy for urachal adenocarcinoma. Rev Urol. 2015;17(1):46–9.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sanchia S. Goonewardene
    • 1
    Email author
  • Raj Persad
    • 2
  • Hanif Motiwala
    • 3
  • David Albala
    • 4
  1. 1.East of England DeaneryNorfolk and Norwich University HospitalNorwichUK
  2. 2.North Bristol NHS TrustBristolUK
  3. 3.Southend University HospitalWestcliff-on-SeaUK
  4. 4.Boston UniversityBostonUSA

Personalised recommendations